BridgeMD
New treatment option for Cigarette Smoking
Official title Menthol, Inflammation, and Nicotine Transition Study
ClinicalTrials.gov ID: NCT06232447
What this study is testing
- What it's testing
- This study will focus on examining the potential impact of menthol flavoring in cigarettes on biomarkers of systemic inflammation as a subclinical indicator of cardiovascular disease risk.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 21 to 85. Healthy volunteers may be eligible.
You may be able to join if
- Men and women between 21-85 years old
- Currently uses menthol cigarettes
- Daily smoking rate of ≥5 cigarettes/day for ≥1 year
- Currently own and regularly use an iOS/Android smartphone device able to download the LifeData application
- Able to read and communicate fluently in English
You likely can't join if
- Currently pregnant or breastfeeding
- Actively trying to quit smoking
- Current heavy alcohol use
- Frequent use of non-menthol cigarettes, other smoking products, or illicit substances
- History of severe medical/psychiatric condition or treatment
The study team makes the final eligibility decision.
Where it's taking place
- North Chicago, Illinois, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 21 years to 85 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include North Chicago, Illinois, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.